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1. Introduction
In the last two decades a lot of attention has been payed on the preparation of nanoscaled
materials and recently, depending on the development of new fabrication and characterization
techniques, materials composed of a few atoms up to hundreds of atoms can be synthesized
and their properties determined easily. Nano sized materials, as compared to their bulk
counterparts, exhibit new characteristic optical, electrical and magnetic properties due to the
enhanced surface to volume ratio and quantum confinement effects emerging in these size
ranges. These new features of nanoparticles offers them the possibility to be used in a wide
range of technological (magnetic data storage, refrigeration), environmental (catalysts,
hydrogen storage), energy (lithium-ion batteries, solar cells) and biomedical applications. In
biomedical applications there are different kind of nanoparticles used like metallic [1],
magnetic, fluorescent (quantum dot) [2,3], polymeric [4,5] and protein-based nanoparticles [6,
7], in which much of the research in this field is focused on the magnetic nanoparticles. In this
review only magnetic nanoparticles, which are composed of a magnetic core surrounded by
a functionalized biocompatible surface shell will be concerned, where several reviews on other
type of nanoparticles are available in the literature. In the scope of the text particular attention
will be payed on superparamagnetic iron oxide (SPIONs), which is beyond the most studied
one among all types of magnetic nanoparticles. In the beginning of the article, the biomedical
applications of magnetic nanoparticles are summarized together with the key factors effecting
the nanoparticles’ performance in these applications. Then the requirement for the surface
treatment of the nanoparticles are discussed in the context of colloidal stability, toxicity
(biocompatibility) and functionalization. Finally, the followed procedures for the surface
coating of magnetic nanoparticles are briefly explained and the different materials used as
surface coatings are listed in detail with examples from literature.
© 2013 Umut; licensee InTech. This is an open access article distributed under the terms of the Creative
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2. Biomedical applications of magnetic nanoparticles
Magnetic nanoparticles (MNP) with dimensions ranging from a few nanometers up to tens of
nanometers, thanks to their comparable or smaller size than proteins, cells or viruses, are able
to interact with (bind to or penetrate into) biological entities of interest [8]. These size advan‐
tages of MNPs together with their sensing, moving and heating capabilites based on the unique
nanometer-scale magnetic and physiological properties give them the possibility to be used in
biomedical applications such as magnetic resonance imaging (MRI), targeted drug delivery
and hyperthermia [9].
In MRI, which is the most promising non-invasive technique for the diagnosis of diseases,
MNPs are used as contrast enhancement agents [10-12]. The improved contrast in MR images
permits better definition and precise locating of diseased tissues (such as tumors) together
with monitoring the effect of applied therapy. The operation of MRI is based on the Nuclear
Magnetic Resonance (NMR) phenomena and the image processing is realized by spatially
encoding of NMR signal of water protons which comes from different volume elements in the
body called voxels. The image contrast in MRI depends mainly on proton density, spin-lattice
(T1) and spin-spin (T2) nuclear relaxation times, differently weighted along different parts
(voxels) of the body. The so-called contrast agents (CAs) themselves do not generate any
signals, yet they contribute to the nuclear relaxation of water protons by creating local magnetic
fields, which are fluctuating in time through different mechanisms like magnetization reversal
and water diffusion [13]. As a consequence, the CAs decrease or increase the MRI signal
intensity in the tissues by shortening both the T1 and T2 relaxation times of nearby protons
resulting darker or brighter points in the image. The contrast enhancement efficiency of CAs
is measured by the relaxivity r1,2, which is defined as the increament of the nuclear relaxation
rates 1/T1,2 of water protons induced by one mM of the magnetic ion. The CAs having a ratio
r2/r1 greater than two, especially at magnetic fields mostly used in MRI tomography (0.5, 1,5
or 3 Tesla), are classified as T2-relaxing (or negative) CAs since they more effectively decrease
T2 rather than T1. On the other side CAs, characterized with a ratio r2/r1 smaller than two, have
more pronounced effect on T1 and hence called as T1-relaxing (or positive) contrast agents [14].
The MNPs showing superparamagnetic property at physiological temperatures generally
serve as T2-relaxing CAs and they negatively improve the image contrast resulting darker spots
where they are delivered. Commercially a wide variety of superparamagnetic iron oxide
(SPIO) based negative CAs are available in the market like Endorem, Sinerem, Resovist,
Supravist, Clariscan, Abdoscan etc., where each of them are used for different puposes or in
different organs in clinical MRI application.
In a second biomedical application called magnetic hyperthermia, which is a thermally
treatment of cancerous cells based on the fact that the cancer cells are more susceptible to high
temperatures than the healthy ones, the MNPs can be used as heating mediators [15,16]. In
this technique after concentrating the MNPs in the region of malignant tissue (by targeting or
by direct injection), the MNPs are made to resonantly respond to a time-varying magnetic field
and transfer energy from the exciting field to the surroundings as heat. By this way using an
alternating field with sufficient intensity and optimum frequency, the temperature of tissue
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can be increased above 40-42 oC and the infected cells could be selectively destroyed. According
to the models describing the heat release mechanisms of MNPs, increasing the frequency and
the amplitude of the alternating field promises to significantly enhance the amount of released
heat, but the limitations imposed by the biological systems restrict these values under a few
tens of kA/m and a few hundreds of kHz for the field strength and frequency, respectively [17].
The MNPs’ heating capacity in magnetic hyperthermia is denoted by Specific Absorbtion Rate
(SAR) or in another term Specific Loss of Power (SLP), which is a measure of the energy
converted into heat per unit mass. As the similar case in MRI CAs, the majority of magnetic
hyperthermia heat mediators investigated to date are based on iron oxide MNPs, where in
these studies the typical values reported for the maximum attained SAR range between 10 and
200 W/g [18-20]. However, it has been also focused on several systems alternative to iron oxide,
where in some of them SAR values 3-5 times larger than those of similar iron oxide MNPs are
attained for the same field parameters [21-22]. Recently, although there are lots of in-vitro
studies about magnetic hyperthermia, the therapy with hyperthermia is still in pre-clinical
stage and only a few studies on human patients are reported [23,24]. However, in cancer
treatment the magnetic hyperthermia is thought to be introduced as a complementary
technique to chemo- and radiotherapy as increasing the effects of these therapies [25, 26].
In another major in-vivo application, the MNPs are used as drug carriers in a magnetic ‘tag-
drag-release’ process called targeted drug delivery. In a drug delivery process the MNPs,
loaded with special drug molecules or conventional chemotherapy agents, are directly
vectorized to tumor cells by targeting ligands on their surfaces or they brought into the vicinity
of target tissue through magnetic forces exerted on them under an applied external magnetic
field. Once the drugs/carriers are concentrated at the diseased site, the drugs are released from
the carriers, again through modulation of magnetic field, enzymatic activity or changes in
physiological conditions such as pH, osmolality or temperature. With this approach, the tumor
cells can be destroyed by concentrating only the required quantity (dose) of drugs at target
specific locations with minimized side effects on healthy tissues. The performance of the
application depends mainly on the drug release kinetics and the cellular uptake of MNPs in
tissues. There are huge number of drug delivery studies in the literature reporting both in-
vitro and in-vivo results on different cell cultures and different types of tumors respectively,
where in these studies several kind of targeting ligands and anticancer drugs are tested and
in most of them again superparamagnetic iron oxide is used as magnetic core [27,28]. Generally
in the design of MNPs for targeted drug delivery, in order to monitor the effect of the therapy,
MRI contrast increament ability of the same MNP system is also investigated [29].
Actually in recent years much more interest has been concentrated on multifunctional MNPs,
in which the above mentioned diagnostic (MRI) and therapeutic (hyperthemia and drug
delivery)  capabilities  are  combined [15,30,31].  Although some MNP-based  MRI  contrast
agents are commercialy available on one side and magnetic hyperthermia is already utilized
in conjunction with other kind of therapies on the other side, MNPs optimized to perform
both  functions  (diagnostic  and  therapeutical)  have  not  been  developed  yet.  Indeed  the
possibility to associate therapeutic effect generated by the heat release and delivered drugs
with the enhanced contrast in MRI images, is extremely appealing since it would provide the
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possibility before heating the tissue to track the particle distribution by MRI, and after the
drug therapy or thermotherapy to have an immediate control of the efficacy of the treat‐
ment itself. In Figure.1 a summarized illustration of biomedical applications has been shown.
Figure 1. Biomedical applications of magnetic nanoparticles (image has been reproduced from A. Lasicalfari et al. [9].
3. Design of MNPs for biomedical applications
In many biomedical applications of MNPs, usually a core/shell structure is required, where
the inorganic magnetic core is surrounded by an outer layer of shell (coating). The successfull
design of MNPs needs a carefull selection of magnetic core and surface coating material, where
the first mainly determines the MNPs’ above mentioned heating, sensing etc. abilities related
with application eficiency and the second specifies the interaction of these MNPs with
physiological environment. In following sections the properties of magnetic core and the
surface coating are discussed in detail.
3.1. Magnetic core
In the selection of magnetic core some important aspects should be taken in the consideration,
such that for the first the magnetic core should be crystalline and smaller than a critical size as
to consist of only one magnetic domain. This ensures that the single-domain nanoparticles
exihibit superparamagnetic behaviour with zero remanent magnetization in the absence and
a very high magnetization (approximately three orders of magnitude greater than paramag‐
netic materials) in the presence of an external field. This physical phenomenon is the key
requirement for biomedical applications since the particles can be dispersed and concentrated
in solution in-vitro or in blood circulation in-vivo, without forming magnetized clusters and
they can also respond to an instantly applied field with some kind of magnetic on/off switching
behaviour. For the second aspect, the size distribution of the magnetic cores should be as
narrow as possible and third, all the magnetic cores in a particular sample should have a unique
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and uniform shape (monodispersed). This is because all the magnetic and physico-chemical
properties strongly depend on the size and shape of the magnetic cores. From an applicative
point of view the size, properly speaking the hydrodynamic size which is the total diameter
of MNP including the coating tickness, is also important for the elongation of MNPs’ circula‐
tion time in blood and for the improvement of their internalization by the cells at the target
tissue such that smaller nanoparticles have bigger chance to reach the target cells and to
penetrate inside them.
In the search of suitable elements for the magnetic core of MNPs, among other magnetic
materials  transition metals  like Fe,  Ni,  Co and Mn are good candidates since they offer
high magnetization values which is important for high performance MRI and hyperther‐
mia applications. However they are not stable and oxidate very quickly yet in the synthesis
step,  if  they are not specially treated.  For this reason transition metal  oxide compounds
(also  called  ferrites)  which  are  stable  and have  acceptable  magnetizations  are  generally
introduced in biomedical applications. Superparamagnetic iron oxide (SPION), belonging
to ferrite family, is the most commonly employed one in biomedical applications. Nano‐
crystalline iron oxides have an inverse spinel crystal structures, where the oxygen atoms
form face centered cubic lattices and iron ions occupy tetrahedral (Td) and octahedral (Oh)
interstitial sites (Figure.2). İron oxide generally exist as two stable forms called magnetite
(Fe3O4) and its γ phase maghemite (γ-Fe2O3),  but there is also a α phase called hematite
(α-Fe2O3), which is not stable and obtained by thermal treatment of magnetite or maghe‐
mite.  In magnetite,  bivalent Fe+2  ions occupy Oh  sites and trivalent Fe+3  ions are equally
distributed between Oh  and Td  sites,  whereas  maghemite,  which can be result  from the
oxidation of magnetite, only contains Fe+2 ions distributed randomly over Oh and Td sites
[32]. In magnetite, since there is the same number of Fe+3  ions in Oh  and Td  sites, which
compensate for each other, the resulting magnetization arises only from the uncompensat‐
ed Fe+2 ions in Oh sites. On the other side the magnetization of maghemite originates from
uncompensated  Fe+3  ions.  However  their  magnetic  behaivours  and  other  properties  are
quite similar, which makes it very difficult to distinguish between them.
Figure 2. The cubic inverse spinel crystal structure of iron oxide showing Td and Oh sites
Alternatively other types of ferrites were also studied for biomedical applications. In these
ferrites, as compared to the iron oxide nanocrystalls, Fe+2 ions are fully or partially replaced
by other transition metals in spinel structure and they represented by a general formula
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(MFe2O4; M=Zn, Ni, Co, Mn). Manganese ferrites (MnFe2O4) serve as potential MRI contrast
agents with largest magnetization among other ferrites [33] and zinc ferrite (ZnFe2O4) nano‐
crystals demonstrated better MRI contrast with respect to similar magnetite nanocrystals [34].
On the other side as regard to magnetic hyperthermia, the use of cobalt ferrites (CoFe2O4),
known by its high magnetic anisotropy energy which is responsible for holding the magneti‐
zation along certain direction, has proven to be a good way since much higher heating rates
were reported for these nanocrystals compared to other ferrites [21]. Another strategy followed
in the design of magnetic core for biomedical applications is the synhesis of mixed ferrites,
where simple ferrites including one kind of magnetic ion except iron are doped with other
kind of magnetic ion. This is generally realized in order to utilize from different outstanding
magnetic features of different ions. For example in hyperthermia application, Co, being a hard
magnetic material, is doped to other ferrites (MFe2O4) in changing concentrations (CoxM1-
xFe2O4; x=concentration) in order to increase the magnetic anisotropy eventually to improve
the heat transfer rate, whereas Zn is added for reducing the Curie temperature of resulting
mixed ferrite [35]. This latter operation permits the tuning of the maximum reached temper‐
ature by heat transfer and prohibits overheating of healthy tissues via the process called self-
controlled hyperthermia [36]. Table.1 summarizes some important magnetic parameters of
transition metal oxides (ferrites) used in biomedical applications.
Another class of materials used as magnetic cores are the magnetic alloy nanoparticles, which
composed of two or three different kind of metals like FeCo, FePt and NiCu. FePt is the most
famous one among these materials due to its chemical stability and high magnetic anisotropy.
Maenosono and Saita have studied FePt nanocrystals and proposed them to be used as high
performance contrast agents and heating mediators in MRI and magnetic hyperthermia,
respectively [37,38].
Ferrites
RT saturation
magnetization
Ms (emu/g)
Anisotropy
constant
K1 (x104 J/m3)
Curie
temperature
Tc (oC)
Superparamagnetic
size
DSP (nm)
Fe3O4 90-100 -1.2 585 25
NiFe2O4 56 -0.68 585 28
CoFe2O4 80-94 18-39 520 14
MnFe2O4 80 -0.25 300 25
Table 1. Some important magnetic parameters (room temperature saturation magnetization, first degree anisotropy
constant, Curie temperature and superparamagnetic transition size) of ferrites [32]
Although MNPs can be prepared with several techniques including inert gas condensation
[39], mechanical milling [40], spray pyrolysis [41], sol-gel [42], vapor deposition [43] and wet
chemical processes [44], all the before mentioned key requirements for biomedical applications
like crystallinity, size and shape uniformity together with other criterias for organic/inorganic
coating of MNP, can be satisfied by hydrothermal chemical decomposition method, which is
the most common one used in the synthesis of MNPs for biomedical applications. In this liquid
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phase synthesis method, basically several organometalic precursors with suitable sitochio‐
metric ratios are put in reaction in the presence of some organic surfactants or polimers. During
the decomposition process at high tempertature, in order to prohibit a possible oxidation,
continously an inert gas is fluxed through the mixture and at the end of the reaction the desired
nanomaterial is obtained as a precipitate. The method enables the control on size of the MNPs
through systematically change of the reaction parameters like concentration, reaction temper‐
ature and reaction time. In the method, MNPs with very narrow size distributions (σ~% 10)
are synhesized and the distribution can be further improved (down to σ~% 5) by subsequently
precipitating, redispersing and centrifuging of the particles, so-called as size selection proc‐
esses (Figure.3). S. Sun and co-workers have published several pioneering papers in this area,
where they have introduced hydrothermal routes for the synthesis of size-controlled MNPs
for the first time and they have synthesized monodispersed iron oxide [45], other transition
metal oxides [46] and iron-platinum [47] nanoparticles by using this method. The other
advantages of the methods are the abilities of large quantity production of MNPs and the
subsequent coating of them which will be explained in detail in the following of the chapter.
Another common technique used in MNP synthesis for biomedical applications is the co-
precipitation method. It has some disadvantages against thermal decomposition method like
lower crystallinity and lower monodispersity but the procedure is easier and at the end of the
procedure larger amount of product can be yield. The method is based on the simultaneous
nucleation and growth of magnetic cores by dissolving metal salt precursors in aquaeous
environment with changing pH and temperature [35]. Alternatively this reaction can be
governed in a confined environment via microemulsion method. In this method the co-
precipitation reaction takes place in some kind of “nano-reactors” called micelles, those are
dispersions of two immiscible liquids like oil-in-water or water-in-oil (reverse micelle). The
main advantage of the microemulsion is to ensure that the reaction occurs in an isolated media
limiting the particle growth and it is possible to control the size of the magnetic core precisely
by changing the size of the micelles [48].
thermometer 
Heater 
Precursor 
injection 
Gas 
flow 
redispersion 
centrifugation 
better 
monodispersity 
surfactant 
assisted 
precipitation 
Figure 3. An illustration of nanoparticle synthesis by high temperature thermal decomposition method and size selec‐
tion processes.
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3.2. Surface coating
In the design of MNPs, except the selection of a suitable magnetic core, fine tuning of surface
coating materials represents a major challenge for the practical use of MNPs in clinical
applications. The coating can consist of long-chain organic ligans or inorganic/organic
polymers, where these ligands or polymers can be introduced during (in-situ coating) or after
(post-synthetic coating) synthesis. During the in-situ coating, which is the procedure followed
in co-precipitation synthesis technique, precursors of magnetic cores and coating materials are
dissolved in the same reaction solution, and the nucleation of magnetic core and the coating
occurs simultaneously. On the contrary in post-synthetic coating, which is the case in MNP
synthesis with thermal decomposition technique, the surface coating materials are introduced
after the formation of magnetic cores. In both procedures in order to link the surface molecules
to magnetic cores, generally two different approaches; either end-grafting or surface-encap‐
sulation are followed. In the former one, the coating molecules are anchored on magnetic core
by the help of a single capping group at their one end, whereas in the latter generally polymers,
already carrying multiple active groups, are attached on the surface of magnetic core with
multiple connections resulting stronger and more stable coatings.
In some cases, surface modification of MNPs can drammatically change the magnetic prop‐
erties hence the performance of the MNPs in biomedical applications depending on which
coating material is used and how these materials are linked on the magnetic core surface as
discussed above. Formation of chemical bonds between coating molecules and surface metal
ions changes the surface spin structure and consequently the magnetic properties of coated
MNPs with recpect to uncoated ones. Actually it is difficult to discriminate between surface
coating and finite size contributions, the latter being the effect of surface spin canting due to
the minimization of magnetostatic energy at the surface and observed also in uncoated
particles [49]. In finite size effect the canted spins at MNP’s surface, do not respond to an
external applied magnetic field as the bulk spins and give rise to a significant decrease in net
magnetization, where this effect becomes dominant in smaller MNPs, since the volume fraction
of disordered surface spins are increased [50]. On the other side, the physical origin of the
surface coating effect on magnetic properties is still unclear and different results were reported
in several studies for different kind of magnetic cores and coating materials. For example,
Vestal and Zhang [51] have investigated the influence of the surface coordination chemistry
on the magnetic properties of MnFe2O4 nanoparticles by capping the 4, 12 and 25 nm sized
MnFe2O4 nanoparticles with a variety of substituted benzenes and substituted benzoic acid
ligands and observed an increase in saturation magnetization, whereas a decrease is reported
by Ngo et al. [52] for citrate coated 3 nm CoFe2O4 nanoparticles. On the other hand, no
significant change in the magnetic properties of 10 nm sized γ-Fe2O3 nanoparticles is observed
for different surface chemical treatments such as NO3, ClO4 and SO4 [53]. Another in-direct
effect of the surface coating on magnetic properties, which should be mentioned, is to reduce
the magnetic interparticle interactions through decreasing the distance between magnetic
cores. This is important since strong interparticle interactions can alter the MNPs’ overall
magnetic properties i.e. superparamagnetic behaivour and diverse it from isolated ones.
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Dormann and Fiorani have published several important papers investigating the magnetic
interparticle interactions and the effect of coating [54-56].
The surface coating of MNPs plays a crucial role in biomedical applications by fulfilling more
than one function at a time. The organic/inorganic surface coating is important for i) prohib‐
iting agglomeration (clustering) of MNPs due to the above mentioned interparticle interactions
and eventually providing the colloidal stability of water/organic solvent based suspensions/
solutions (ferrofluids) prepared with MNPs ii) providing biocompatibility of MNPs by
preventing any toxic ion leakage from magnetic core into the biological environment iii)
serving as a base for further anchoring of functional groups such as biomarkers, antibodies,
peptides etc. In the next paragraphs these functions of MNP’s surface coating are discussed in
detail.
3.2.1. Stability
The stabilization of the MNPs is crucial to obtain magnetic colloidal ferrofluids that are stable
against aggregation both in a biological medium and in a magnetic field. By coating the MNPs,
direct contacts among the particles are prevented by surface ligands and polymer chains
extending into the medium. Therefore, no aggregates of particles will be formed or the rate of
precipitation will be decreased depending on the degree of covarege of coating on the particles
and the thickness of the coating layer. The stability of a magnetic colloidal suspension results
from the equilibrium between attractive (magnetic dipol-dipol, van der Waals) and repulsive
(electrostatic, steric) forces [57]. Controlling the strength of these forces is a key parameter to
elaborate MNPs with good stability. A suitable surface coating should not only keep the MNPs
apart from each other, eliminating the distance dependent attractive forces but should also
ensure the charge neutrality and steric stability of MNPs in aquaeous or organic media. The
MNPs capped by hydrophilic surfactants like dodecylamine, sodium oleate can be easily
dispersed in aqua but when they are stabilized by hydrophobic surfactants like oleic acid,
oleylamine, which is the frequent case in the MNP synthesis with thermal decomposition
method, they can only be dispersed in nonpolar solvents such as hexane, toluene or weak polar
solvents such as chloroform. Therefore in order to stabilize these MNPs in aquaeous media,
different kind of polymers can be introduced on MNPs either by end-grafting or surface
encapsulation or as an alternative strategy, the MNPs can be capped with amphiphilic
molecules, consisting both hydrophobic and hydrophilic regions at their opposite ends via
hydrophobic interactions resulting micelle-like structures [58].
3.2.2. Toxicity (Biocompatibility)
Another critical point which should be considered in the design of MNPs for biomedical
applications is the toxicity of magnetic ion included in the magnetic core. The surface coating
ensures a double- sided isolation both preventing the release of toxic ions from magnetic core
into biological media and shielding the magnetic core from oxidization and corrosion. Among
different types of MNPs iron oxide is by far the most commonly employed one for in vivo
applications since iron is physiologically well tolerated. This is partially because the body is
designed to process excess iron and it is already stored primarily in the core of the iron storage
Surface Modification of Nanoparticles Used in Biomedical Applications
http://dx.doi.org/10.5772/55746
193
protein called ferritin. Manganese (Mn) and Zinc (Zn) are other essential trace elements in
human bodies, but their tolerable limit is much lower than iron’s, so a surface manipulation
is required [59]. Other elements, such as Co and Ni, which are desired for their high perform‐
ance in hyperthermia application, are highly toxic and necessitates proper coatings when they
are used in vivo. During in vivo applications once the MNPs are injected into the body, they
are recognized by the body’s major defence system (also known as reticuloendothelial system
(RES)), which eliminates any foreign substance from blood stream. In this “opsonisation”
process, MNPs are attacked by plasma proteins, which are sent by RES and are responsible for
the clearance of MNPs. The specific surface coatings prevent the adsorbtion of these proteins,
thus elongate the MNPs circulation time in blood and maximize the possibility to reach target
tissues [60].
3.2.3. Functionalization
In order to enable the direct use of MNPs in biomedical applications, the MNPs should be
further functionalized by conjugating them with functional groups. The surface coating
provides suitable base for the attachment of these functional groups on MNPs. These groups
such as antibodies, peptides, polysaccharides etc. permit specific recognition of cell types and
target the nanoparticles to a specific tissue or cell type by binding to a cell surface receptor.
Usually some linker molecules such as 1-ethyl-3-(3-dimethylaminopropyl) carbodi-mide
hydrochloride (EDCI), N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP), N-hydroxysuc‐
cinimide or N, N’-methylene bis acrylamide (MBA) are also used to attach the initial hydro‐
philic coated molecules to these targeting units [58]. In practice although the targeted cell
population is recognized with high specifity, the fraction of targeted cells interacting with the
antibody attached MNP is relatively low. Actually the effectiveness of biomedical applications
depends more on cell-nanoparticle interactions than particle targeting. It is indicated that the
cell membranes plays an important role in cell-nanoparticle interactions, either particle
attachment to the cell membrane or particle uptake into the cell body. In order to clarify the
nature of cell-nanoparticle interactions, usually phospholipid bilayers mimicking a cellular
membrane or living cell membranes are used in studies.
3.2.4. Surface coating materials
For utilizing all the above mentioned functionalities of MNP’s surface coating, different
criterias of inorganic/organic molecules and polymers such as hydrophobic or hydrophilic,
neutral or charged, synthetic or natural etc. are considered. The polymer coatings can be
classified as natural polymers such as chitosan, dextran, rhamnose or synthetic polymers like
polyethyleneglycol (PEG), polyvinyl alcohol (PVA), polyethyleneimine (PEI), polyvinylpyro‐
lidone (PVP). In some cases other organic molecules including oleic acid, oleylamine, dode‐
cylamine and sodium oleate are also used to enhance water solubility of MNPs. On the other
side, there are very less number of inorganic materials available for MNPs surface coatings, in
which gold (Au) and silica (SiO2) are the most common used ones due to their biocompatibility.
In Figure.4 a representative sketch of MNPs with different types of coatings are shown. In the
next paragraphs, these coating materials are introduced in detail by summarizing their
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outstanding properties and by discussing their feasibility in clinical applications with recent
examples from literature.
magnetic 
core 
magnetic 
core 
magnetic 
core 
Figure 4. A representative sketch of MNPs with different types of surface coatings: (a) inorganic materials (b) long
chain organic molecules (c) organic polymers
3.2.4.1. Inorganic surface coatings
Gold (Au)
Nanosized gold (Au) attracts too much attention due to its unique physical properties
combined with chemical stability, biocompatibility and surface properties which permits its
attachment to different chemical moieties. Surface modification of MNPs with biocompatible
gold, both provides the in-water stabilization of particles by preventing their agglomeration
and enables their fuctionalization by the attacment of several ligands on them. From applica‐
tive point of view, it also maintains the incorporation of some optical properties on MNPs
promoting their use in dual-mode (optical and magnetic diagnosis) applications. Gold
nanosurface shows surface plasmon resonance (SPR) phenomena, which triggers MNPs to
strongly absorb and scatter near infrared wavelengths (Surface Enhanced Raman Scattering-
SERS) accepted as “clear window” for deeper penetration of light into the human tissue [61].
In this respect gold modified MNPs, besides other applications, can simultaneously be used
in SERS imaging, where detection in molecular level is possible enabling the diagnosis of
diseases at very early stages. E. Umut et al. [12] have synthesized organically coated mono‐
dispersed gold-iron oxide hybrid nanoparticles following the chemical procedures introduced
by W. Shi [62] and H. Yu [63], and showed that the superparamagnetic hybridnanoparticles
have MRI contrast enhancement abilities associated with optical properties based on SPR
phenomena, where the optical SPR absorbance depens on the geometry of synthesized hybrid
nanoparticles. Similarly X. Ji et al. [64] have fabricated hybridnanoparticles where superpar‐
amagnetic iron oxide nanoparticles were embedded in silica and further coated with gold
nanoshell, and they exihibit that the resulting nanoparticles both can improve the MRI contrast
and have efficient photothermal effects when exposed to near infrared light. In another study
H. Y. Park et al. [65] have synthesized Fe3O4@Au coreshell nanoparticles with controllable size
ranging from 5 to 100 nm following a hetero-interparticle coalescence strategy and demon‐
strated the surface protein-binding properties and SERS effectiveness of synthesized nano‐
particles. There are lots of similar studies in the literature, where gold nanoparticles or
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nanosurfaces are introduced in different “smart” nanostructures for utilizing its optical
properties together with surface binding properties in multifunctional manner [66-69].
Silica (SiO2)
Another inorganic but “biofriendly” material used as MNPs’ coating is silica, which is known
for its chemical stability and easy-to-formation. The first advantage of having surface enriched
in silica is the presence of silanol groups, which can easily react with coupling agents providing
strong attachment of surface ligands on MNPs [70]. As a second advantage, silica coating
increases the stabilization of MNPs in liquid dispersions both by preventing the dipolar
attractions and by increasing the surface charges hence the electrostatic repulsions between
particles in non-aquaeous dispersions. There are several succesfull methods available for the
formation of silica coating, in which the mostly used one is the Stöber method, where a
hydrolysis reaction of tetraethyl ortosilicate (TEOS) is governed in alcohol media under
catalysis by ammonia [71]. In different studies reporting the synthesis of silica coated iron
oxide nanoparticles, Y. H. Deng et al. have used Stöber method and obtained spherical
coreshell nanoparticles by the condensation of TEOS in sol-gel form on pre-formed magnetite
nanoparticles and have investigated the morphology and the thickness of the coating by
systematically changing the used alcohol type or the amount of alcohol, amonia and TEOS [72].
S. Santra et al. have applied water-in-oil microemulsion method again for the coating of
previously synthesized iron oxide nanoparticles by using different nonionic surfactants and
obtained as small as 1-2 nm and very uniformly sized (with standard deviation less than 10%)
nanoparticles [73]. In another study D. K. Yi and colleagues, again by following a reverse
microemulsion method, have synthesized homogenous silica-coated SiO2/Fe2O3 nanoparticles
with changing shell thickness at first stage and then they used these nanoparticles to derive
mesoporous silica-coated SiO2/Fe2O3 MNPs and hollow SiO2 nanoballs [74]. In these studies
the effect of coating and coating tickness on the magnetic properties of iron oxide were also
investigated. As being in Au coated MNPs, attachment of different functional components to
silica encapsulated MNPs either by embedding into or binding onto silica shell, smart
engineering nanostructures realizing more than one function can be prepared [75,76].
3.2.4.2. Organic surface coatings
Chitosan
Natural polymers and their derivatives have been widely utilized for coating of MNPs for
in vivo applications. This is because such polymers are inexpensive and are known to be
nonimmunogenic  and  nonantigenic  in  the  body.  They  are  usually  anchored  onto  the
surfaces of MNPs through carboxylate groups on their side chains. Chitosan is a natural
polysaccharide cationic polymer, which is nontoxic, hydrophilic and biodegredable. There
are lots of studies introducing chitosan as MNP carriers with the aim of use in biomedi‐
cal applications. Y. Chang and D. Chen [77] have reported the preparation of 13,5 nm sized
chitosan coated magnetite nanoparticles, where the chitosan was first carboxymethylated
and  then  covalently  bound  on  the  surface  of  preformed  magnetite  nanoparticles  via
carbodiimide activation.  They have also demonstrated that  the synhesized nanoparticles
can  be  efficiently  used  in  magnetic  ion  separation.  Thereafter  instead  of  this  two  step
Modern Surface Engineering Treatments196
suspension crosslinking approach, J. Zhi et al. proposed an alternative method for in situ
preparation of chitosan-magnetite nanocomposites in water-in-oil  microemulsion [78].  By
this method they have synthesized spherical chitosan nanoparticles in varying size from
10 nm to 80 nm with cubic shaped magnetite core. D. Kim et al. have prepared chitosan
and  -its  derivative-  starch  coated  iron  oxide  nanoparticles  with  the  aim  of  treatment
carcinoma cells  by magnetic  hyperthermia [79].  After  performing in vitro cell  cytotoxity
and affinity  tests  together  with  magneto-caloric  measurements  on  magnetic  fluids,  they
have shown that targeting of MNPs to cells was improved by using a chitosan coating and
the coated MNPs are expected to be promising materials for use in magnetic hyperther‐
mia. In another study published by Y. Ge et al. chitosan coated maghemite nanoparticles
were  modified  with  fluorescent  dye  by  covalent  bonding  for  dual-mode  high  efficient
cellular  imaging.  They  have  shown  that  prepared  nanoparticles  could  be  efficiently
internalized  into  cancer  cells  and  serves  as  MRI  contrast  agents  and optical  probes  for
intravital fluorescence microscopy [80].
Dextran
Another natural polymer is dextran, which is a neutral, branched polysaccharide composed
of glucose subunits. Dextran is one of the most frequently chosen polymer because of its high
biocompatibility. The studies conducted in order to find the biocompatibility of dextran have
shown that the surface-immobilized dextran on MNPs is stable in most tissue environment,
because dextran is resistant to enzymatic degradation [81]. However, the cellular uptake of
dextran coated MNPs are not sufficient for most biomedical applications. One strategy to
overcome this handicap has been reported by A. Jordan et al. as creating aminosilane groups
on the surface of MNPs and by following this approach in vitro cellular uptake of such
nanoparticles in carcinoma and glioblastoma cells was found to be thousand times higher than
that of only dextran-coated MNPs [82]. With this method also much more efficient hyperthe‐
mia results have been obtained. Another pathway to increase the internalization of dextran
coated particles by tumor cells is the further coupling of them with specific ligands. Some
authors, with the aim of achieving better localized MRI contrast, have attached “transferrin”
onto dextran coated MNPs and the cellular uptake of these ligand modified MNPs were two
or four times higher compared to unmodified ones [83, 84]. There are many studies reporting
different synthesis methods for preparing dextran-coated iron oxide nanoparticles [85,86] and
investigating their interaction with cells [87,88].
Polyethylene Glycol (PEG)
PEG is a neutral, hydrophilic, linear synthetic polymer that can be prepared with a wide range
of terminal functional groups. By varying these functional groups, PEG can be binded to
different surfaces. PEG coated MNPs reveal excellent stability and solubility in aquaeous
dispersions and in pysiological media. Moreover the implementation of PEG as a surface
coating of MNPs drammatically increases the blood circulation time of MNPs, enhancing their
hinderence from the body’s defence system. But as compared to multi-branched dextran
coating, surface immobilized PEG permits limited grafting of further macromolecules since it
has only one site available for ligand coupling. Related with the cellular uptake performance,
Zhang et el. [89] have shown that the amount of internalized PEG coated MNPs into mouse
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macrophage cells are much lower than uncoated MNPs. However, for breast cancer cells PEG
modification of MNPs promotes better internalization of particles, where this situation is
explained with the high solubility of PEG in physiological media hence the possibility of its
diffusion into cell membranes [90]. In any case, as being in dextran coated MNPs, additional
surface coupling of targeting ligands on PEG modified MNPs increases their cellular uptake.
In order to attain a better intracellular hyperthermia efficacy, M. Suzuki et al. have attached
monoclonal IgG antibody on the surface of PEG-modified magnetite nanoparticles and
showed that cellular uptake of particles is improved [91].
Polymers / organic molecule Properties Advantages / Disadvantages
Chitosan -natural, cationic,
hydrophilic, linear,
biodegredable
-can be used in non-viral gene delivery
Dextran -natural, branched,
hydrophilic, biocompatible
-permits the anchoring of biovectors and
drugs when functionalized with amino
groups
Polyethyleneglycol (PEG) -synthetic, neutral,
hydrophilic, linear,
biocompatible
-remain stable at high ionic strengths of
solutions with varying PH values, enhances
blood circulation time (a few hours), permits
functionalization
Polyethyleneimine (PEI) -synthetic, cationic, linear or
branched, non-
biodegredable, toxic
-forms strong covalent bonds with MNP’s
surface, can be used for DNA and RNA
delivery, but exhibit cytotoxity
Polyvinylealcohol (PVA) -synthetic, hydrophilic,
biocompatible
- irreversibly binds on MNP’s surface but can
be used in temperature sensitive heating or
drug release applications due to its
decomposition temperatures (40-50 oC),
Polyvinylpyrolidone (PVP) -synthetic, branched,
hydrophilic
-forms covalent bonds with drugs containing
nucleophilic functional groups
Table 2. Some properties of different organic surface coating materials
Polyvinyl Alcohol (PVA)
PVA is a hydrophilic, synthetic polymer. Coating of MNPs surface with PVA enhances the
colloidal stability of ferrofluids prepared with these MNPs. But it has been suggested that PVA
irreversibly binds on MNPs surface due to interconnected network with interface, which
means a fraction of PVA remains associated with the nanoparticles despite repeated washing
[92]. The residual PVA, in turn, influence different properties of nanoparticles such as particle
size, zeta potential and surface hydrophobicity. Importantly, nanoparticles with higher
amount of residual PVA had relatively lower cellular uptake. It is proposed that the lower
intracellular uptake of nanoparticles with higher amount of residual PVA could be related to
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the higher hydrophilicity of the nanoparticle surface [93]. A. P. Fink et al. have coated 9 nm
sized iron oxide nanoparticles with unfunctionalized or carboxylate, amine or thiol function‐
alized PVA and observed that nanoparticles coated with PVA and carboxyl and thiol func‐
tionalized PVA were non-toxic to melanoma cells, whereas for the amine functionalized PVA
nanoparticles, some cytotoxicity was observed particularly when the polymer concentrations
were high [94].
Polyethyleneimine (PEI)
PEI is a cationic, synthetic polymer and exist either as linear or branched forms. Although PEI
is toxic and non-biodegredable, it has long been used for gene delivery thanks to its ability to
bind with DNA [95]. Since it is a cationic polymer it can further interact with a wide variety
of negatively charged complexes. Recently F. M. Kievit et al. have developed a complex MNP
system, which is made of a superparamagnetic iron oxide nanoparticle (NP), which enables
magnetic resonance imaging, coated with a novel copolymer comprised of short chain
polyethylenimine (PEI) and poly(ethylene glycol) (PEG) grafted to the natural polysaccharide,
chitosan (CP), which allows efficient loading and protection of the nucleic acids [96]. In this
study they have illustrated the function of each component by comparative experiments and
proposed that the designed complex MNP system is a potential candidate for safe in vivo
delivery of DNA for gene therapy.
As should be summarized, there is a wide variety of coating materials could be attached on
MNPs’ surfaces by following different coating procedures and each of these materials have
different advantages and disadvantages in biomedical applications depending on their
characteristic properties like hydrophilicity, neutrality and structure. Table.2 lists some
properties and outstanding advantages / disadvantages of different organic surface coating
materials.
4. Conclusions
In the last two decades, a lot of attention has been devoted to synthesis and characterization
of functionalized iron or other transition metal oxide based MNPs, which have potential use
in diagnosis and/or therapy in cancer treatment. These MNPs can act as contrast enhancement
agents in diagnostic applications such as MRI and/or they can be used as carriers or localy heat
releasers in therapeutic applications such as targeted drug delivery and magnetic hyperther‐
mia, respectively. In the design of MNPs, the selection of the magnetic core and its surface
modification with several organic/inorganic materials and polymers plays the major role
effecting the performance of MNPs in these biomedical applications. Among different
available magnetic ions, the correct selection of the magnetic core for MNPs requires careful
and balanced consideration on material’s properties such as chemical stability, toxicity and
magnetization. The magnetic core further should be crystalline, small than a critical size and
have a narrow size distribution where all these requirements together with proper in-situ or
post synthetic surface coatings are satisfied by chemical methods like co-precipitation and
thermal decomposition method. The surface coating is important for ensuring the biocompat‐
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ibility, colloidal stability and functionalization of MNPs, where a wide variety of coating
materials are available like organic molecules/ polymers such as chitosan, dextran, Polyethy‐
leneglycol (PEG), Polyethyleneimine (PEI), Polyvinylalcohol (PVA) or inorganic materials like
silica and gold. Although much progress has been made on the fabrication of MNPs with
delicate structure and enhanced surface properties, in using these MNPs for in vivo applica‐
tions, major challenges still present like degredation, clearence of MNPs in the body, particle-
cell interactions and changing physiological conditions like pH, temperature, blood pressure
etc. which makes difficult to predict the behaivour of MNPs in biological medium.
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